KANHIBIQ Trademark

Trademark Overview


On Monday, July 13, 2020, a trademark application was filed for KANHIBIQ with the United States Patent and Trademark Office. The USPTO has given the KANHIBIQ trademark a serial number of 79293537. The federal status of this trademark filing is REGISTERED as of Tuesday, January 26, 2021. This trademark is owned by NOVARTIS AG. The KANHIBIQ trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
kanhibiq

General Information


Serial Number79293537
Word MarkKANHIBIQ
Filing DateMonday, July 13, 2020
Status700 - REGISTERED
Status DateTuesday, January 26, 2021
Registration Number6253864
Registration DateTuesday, January 26, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 10, 2020

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 25, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Saturday, March 20, 2021NOTIFICATION PROCESSED BY IB
Sunday, February 28, 2021FINAL DISPOSITION NOTICE SENT TO IB
Saturday, February 27, 2021FINAL DISPOSITION PROCESSED
Thursday, February 25, 2021GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, January 26, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, November 10, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 10, 2020PUBLISHED FOR OPPOSITION
Wednesday, October 21, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 5, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 5, 2020ASSIGNED TO EXAMINER
Friday, October 2, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 2, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 2, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, October 2, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 2, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 2, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 29, 2020APPLICATION FILING RECEIPT MAILED
Friday, September 25, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, September 21, 2020LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, September 17, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB